New Key Publication: The chemotherapeutic drug doxorubicin does not exacerbate p16Ink4a-positive senescent cell accumulation and cardiometabolic disease development in young adult female LDLR-deficient mice
Highlights
- Doxorubicin treatment induces acute gonadal white adipose tissue inflammation.
- DOX does not induce p16Ink4a+-senescent cells in young adult female Ldlr−/−-p16-3MR mice.
- DOX treatment results in a long-term reduction in gonadal white adipose tissue mass.
- Long-term cardiometabolic health in young adult female HFC-diet-fed mice is not affected by DOX.
- Clearance of p16Ink4a+-senescent cells does not improve diet-induced atherosclerosis.
Authors:
- Andrea C Postmus
- Janine K Kruit
- Roos E Eilers
- Rick Havinga
- Mirjam H Koster
- Yoshikazu Johmura
- Makoto Nakanishi
- Bart van de Sluis
- Johan W Jonker
Read more: Toxicology and Applied Pharmacology: https://www.sciencedirect.com/science/article/pii/S0041008X23001709?via%3Dihub
| Last modified: | 24 April 2023 10.05 a.m. |
More news
-
26 April 2023
Royal Decorations for UG staff members
Two professors nominated by the University of Groningen have been awarded Royal Decorations on Tuesday 26 April. Professor K.U. Loos is appointed Knight of the Order of the Netherlands Lion. She received this honour from Mayor K. Schuiling at...
-
26 April 2023
Cisca Wijmenga in Raad van Toezicht Hanzehogeschool
Cisca Wijmenga treedt per 1 september 2023 toe tot de Raad van Toezicht van de Hanzehogeschool.
-
25 April 2023
Response to the letter to the House of Representatives regarding internationalization
The Board of the University of Groningen has taken note of the Letter to the House of Representatives regarding internationalization in higher education, sent to the House on Friday 21 April by the Minister of Education, Culture and Science Robbert...